Press Release: MBCGA Special Event- 2025 Annual Educational Conference

 FOR IMMEDIATE RELEASE

October 2025: Advancing Care, Research, and Support for Men Facing Breast Cancer

May 2025 — The Male Breast Cancer Global Alliance (MBCGA) is proud to announce its 2025 Annual Educational Conference, a two-day virtual event dedicated to raising awareness and advancing education about male breast cancer. The conference will take place via Zoom on October 24-25, 2025, offering a platform for global experts, clinicians, researchers, and patient advocates to share the latest in research, clinical trials, treatment strategies, and patient support services.

This year's conference continues the Alliance’s mission of addressing the unique challenges faced by men with breast cancer, a rare but impactful diagnosis affecting thousands of families worldwide. The event will feature internationally recognized speakers presenting groundbreaking research, innovative care models, and advocacy efforts tailored to this often overlooked patient population.

Featured speakers include:

• Dr. Jose Pablo Leone — Director of the Program for Breast Cancer in Men, Associate Professor of Medicine at Harvard Medical School, and a specialist at Dana-Farber Cancer Institute in Boston. Dr. Leone will provide an important update on the ETHAN Trial, a Phase II endocrine study specifically focused on male breast cancer patients.

• Dr. Ben Park — Director of the Vanderbilt-Ingram Cancer Center and Professor of Medicine at Vanderbilt University, Nashville, TN. Dr. Park is expected to discuss forthcoming research initiatives in male breast cancer.

• Dr. Fatima Cardoso — Director of the Breast Unit at Champalimaud Clinical Center in Lisbon and Founder of the Advanced Breast Cancer Global Alliance (ABC Global Alliance). Dr. Cardoso brings extensive expertise in global advocacy and treatment innovation.

• Dr. Don Dizon — Director of the Pelvic Malignancies Program at Lifespan Cancer Institute and Director of Medical Oncology at Rhode Island Hospital. A leader in the field of cancer survivorship and sexual health, Dr. Dizon will speak on “Thriving and Palliative Care: What It Is and What It Is Not.”

• Dr. Robert Bard- Director of Bard Cancer Diagnostics and founder of the AngioInstitute in NYC. As a triple board certified radiologist, Dr. Bard has pioneered advanced ultrasound imaging for early detection screening, 2nd opinion scanning and recurrence monitoring of male breast cancer.

• Representatives from ABCD: After Breast Cancer Diagnosis, who will introduce their mentor training program designed to support men navigating a breast cancer diagnosis.

The conference will be structured over two half-day sessions, allowing attendees from different time zones and clinical backgrounds to participate. Topics will include updates on clinical trials, survivorship strategies, integrative care options, and peer-support initiatives.

“This conference isn’t just about awareness,” says Cheri Ambrose, President / CEO of at the Male Breast Cancer Global Alliance. “It’s about creating a dedicated space for science, advocacy, and community-building that directly benefits men diagnosed with breast cancer and their loved ones.”

Event Details:

Dates: October 24-25, 2025

Location: Virtual (via Zoom)

Registration: Opening in July at [Insert Website]

For media inquiries, speaker interviews, or sponsorship opportunities, please contact:

[Your Name]

[Your Title]

[Your Email]

[Your Phone Number]

About the Male Breast Cancer Global Alliance:

The Male Breast Cancer Global Alliance is an international advocacy organization committed to supporting, educating, and empowering men diagnosed with breast cancer, their families, and the medical professionals who care for them. Through education, research collaboration, and awareness campaigns, the Alliance works to improve outcomes and eliminate disparities in male breast cancer care.

-----------------------------------------------------------------------------------------------------------------------------

THIS MESSAGE IS BROUGHT TO YOU BY THE MALE BREAST CANCER GLOBAL ALLIANCE

The Male Breast Cancer Global Alliance (MBCGA) is leading the charge in awareness, education, and support for men affected by this disease. This organization has built a worldwide network of survivors, advocates, researchers, and healthcare professionals working to shatter the stigma and silence surrounding male breast cancer. They’ve played a crucial role in pushing for more inclusive research, advancing public health messaging, and ensuring men have access to the resources they need. Through tireless advocacy and collaboration, MBCGA has helped get male breast cancer recognized in global cancer policy and has elevated the voices of countless survivors. Their data-driven campaigns and survivor-led storytelling have reached millions, and their partnership with Bard Diagnostics is all about scaling that impact through accessible genetic testing.

 

RELATED RESOURCES

Under a dedicated partnership with the Male Breast Cancer Global Alliance, BARDDIAGNOSTICS established key programs including: EARLIER DETECTION, PREDISPOSITION GENE TESTING, FIGHT RECURRENCE, ACTIVE SURVEILLANCE AND THE 2ND OPINION SCAN. For the many MEN who seek a significantly improved lifestyle or an upgrade in personalized healthcare, getting better answers about your state of health is paramount and IT ALL STARTS WITH STATE OF THE ART DIAGNOSTICS. The visionary paradigm that makes up true personalized medical care involves the integration between modalities, a collaboration between specialists and an upgrade in their strategic approach and you'll find it all at BardDiagnostics. 

UNCOVERED – Shedding Light on Male Breast Cancer

The first official newsletter from the Male Breast Cancer Global Alliance, launched in proud partnership with AngioMedical Media and the Integrative Cancer Resource Society. Rooted in the belief that education is power, UNCOVERED delivers essential news, scientific updates, and survivor stories to inform and inspire. Each issue is packed with the latest in male breast cancer research, treatment innovations, and advocacy efforts from around the globe. Whether you're a patient, caregiver, or medical professional, UNCOVERED is your trusted source for facts and forward-thinking perspectives. Join us in uncovering the truth—and empowering lives through knowledge. (visit our regularly updated Newsletter)

The INTEGRATIVE CANCER RESOURCE SOCIETY is a self-funded (Linkedin Based) independent volunteer group of non-profit foundations/charities, researchers, educators, community leaders and survivors. Under the spirit of collaboration and partnership, we are joined to bring a new level of support to cancer patients, survivors and all those seeking current information about cancer care. We form a unique network of support for one another- while driven to help those who need additional resources, technical updates or empowerment on the road to recovery. ICRS uses the power of the "interweb" to reach a global audience and a network of resources beyond our local borders. We have engaged some of the most impressive minds, perspectives and resources and enjoyed the exchange of vital information that is useful to all. Thanks in part to digital collaboration, these "foreign" connections have always been a part of our cancer crusade, now joining us in what we call "BORDERLESS MEDICINE".

In great support of a the global movement of NON-INVASIVE medicine, we proudly introduce the INTEGRATIVE HEALTH RESEARCH CENTER by AngioInnovation Research (501c3). This New York city-based diagnostic imaging validation lab is established to clinically identify the efficacy, performance and supportive claims set by non-invasive therapeutics and diagnostic solutions. Co-founded by Dr. Robert L. Bard, the IHRC offers a non-profit, non-commercialized testing option for health-related innovations who seek an independent and impartial reporting through single-case pilot studies or IRB-Based clinical trials. The IHRC employs credentialed medical professionals and specialists in clinical research whose experience contributes to the unique strategic approach of each test study. (Visit: the AngioInstitute website)

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.